Scarica l'app Stockscreener
4.31
2.62%
0.11
Dopo l'orario di chiusura:
4.31
Precedente Chiudi:
$4.20
Aprire:
$4.16
Volume 24 ore:
24,177
Relative Volume:
1.79
Capitalizzazione di mercato:
$6.76M
Reddito:
-
Utile/perdita netta:
$-7.24M
Rapporto P/E:
-16.88
EPS:
-0.2554
Flusso di cassa netto:
$-11.29M
1 W Prestazione:
-9.07%
1M Prestazione:
+11.43%
6M Prestazione:
-47.44%
1 anno Prestazione:
-97.23%
Intervallo 1D:
$3.77
$4.6252
Intervallo di 1 settimana:
$3.77
$6.80
Portata 52W:
$3.576
$183.59
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Nome
Curanex Pharmaceuticals Inc
Settore
Industria
Telefono
718-673-6078
Indirizzo
2 JERICHO PLAZA,, JERICHO
Compare CURX vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
4.31 | 6.59M | 0 | -7.24M | -11.29M | -0.2554 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Curanex Pharmaceuticals Inc Borsa (CURX) Ultime notizie
Curanex (NASDAQ: CURX) Achieves Nasdaq Compliance Following $1.00 Bid Price Recovery - Kalkine Media
Curanex Pharmaceuticals Regains Nasdaq Minimum Bid Price Compliance - Minichart
Curanex Pharmaceuticals Regains Nasdaq Compliance After Reverse Split - TipRanks
Curanex Pharmaceuticals regains Nasdaq compliance after 1-for-20 reverse split - TradingView
Curanex Pharmaceuticals Inc Common Stock (NASDAQ: CURX) Stock Price, News & Analysis - Kalkine
Curanex Pharmaceuticals Inc (CURX) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Curanex Announces Reverse Stock Split to Maintain Nasdaq Listing - TipRanks
Enterprise value to EBIT forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Curanex Pharmaceuticals Inc Q2 2026: Net income $(3.29M), EPS $(0.12) — 10-Q Summary - TradingView
CURX: Net loss rose to $6.4M as R&D spending increased; cash shortfall raises going concern doubts - TradingView
Curanex Pharmaceuticals (CURX) Edges Up 3.68% as Micro-Cap Biotech Holds Key SupportVWAP Breakout - Vinanet
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Curanex Pharmaceuticals (CURX) Jumps 7.33% to $0.20 as Buyers Defend Key Support ZonePrice Target - dars.gov.et
Curanex Pharmaceuticals (CURX) Advances 7.33% as Shares Approach Key Resistance at $0.21Dark Pool Prints - dars.gov.et
Curanex Pharmaceuticals Inc - TradingKey
Curanex Pharmaceuticals (CURX) Holds at $0.20 as Modest Gain Breaks Recent StagnationExtension Target - vinanet.vn
Curanex Pharmaceuticals (CURX) Gains 8.2% as Stock Approaches Key ResistanceMFI Divergence - vinanet.vn
CURX|Curanex Pharmaceuticals Inc|Price:0.183|Chg%:-0.005 - TradingKey
Curanex Pharmaceuticals Inc (CURX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Curanex Pharmaceuticals Inc (CURX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CURX|Curanex Pharmaceuticals Inc|Price:0.205|Chg%:+0.014 - TradingKey
Curanex Pharmaceuticals Inc (CURX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Curanex Pharmaceuticals Inc (CURX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Curanex Pharmaceuticals Inc (CURX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Curanex Pharmaceuticals Inc (CURX) Institutional Confidence - TradingKey
CURX|Curanex Pharmaceuticals Inc|Price:0.222|Chg%:+0.009 - TradingKey
Curanex Pharmaceuticals Inc (CURX) Cash Flow - TradingKey
Curanex Pharmaceuticals Inc (CURX) Balance Sheet - TradingKey
Curanex Pharmaceuticals Inc (CURX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
- po-news-eg.net
Curanex Pharmaceuticals (CURX) Slides 6% as Stock Tests Key Support at $0.18Risk Parity Rebalance - vinanet.vn
Curanex Pharmaceuticals Inc Revenue Breakdown – NASDAQ:CURX - TradingView
CURX Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Curanex Pharmaceuticals (CURX) Drops 5.73%: Critical Support at $0.20 in PlayChannel Breakout - dars.gov.et
Curanex Pharmaceuticals (CURX) Edges Higher on Modest Gains, Testing Key Resistance at $0.23Cup and Handle - dars.gov.et
Curanex Pharmaceuticals (CURX) Edges Higher as Bulls Defend Key $0.26 Support LevelFactor Rotation - dars.gov.et
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market SessionGain Therapeutics (NASDAQ:GANX), BNB Plus - Benzinga
Form DEF 14C Curanex Pharmaceuticals Inc For: 29 June By Investing.com - Investing.com Nigeria
Curanex (CURX) OKs 5.7M-share incentive plan and 1:10–1:50 reverse split - Stock Titan
Enterprise value to EBITDA forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Price to book forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Price to sales forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Price to earnings forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Enterprise value to revenue forward of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Number of shareholders of Curanex Pharmaceuticals Inc – NASDAQ:CURX - TradingView
Curanex Pharmaceuticals (NASDAQ: CURX) approves 5.7M‑share plan and 1:10–1:50 reverse split - Stock Titan
Curanex Pharmaceuticals Inc (CURX) Valuation: PE, PB & Fair Value Analysis - TradingKey
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PMCB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Curanex Pharmaceuticals Inc Azioni (CURX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):